US Appeals Court Upholds NIH Research Funding Rates Amid Trump Admin Attempt to Cut Costs.
A US appeals court has agreed with a lower-court ruling that the Trump administration's attempt to drastically cut costs for university research funding was blocked by Congress. The NIH policy change, which would have imposed a uniform 15% flat rate on indirect costs, would have been catastrophic for many universities, with many potentially being forced into financial ruin.
Indirect costs cover expenses such as utilities, facilities for research animals, and building maintenance that are not directly associated with the research project itself. These costs can be quite high due to variations in location, where universities in urban areas must pay more for buildings and staff salaries than their rural counterparts.
The NIH had attempted to change these rates from a negotiated system where costs were estimated using formulas provided by the agency. The Trump administration sought to set an arbitrary flat rate of 15% across all grants.
However, Congress intervened long ago in this issue when they attached a rider to the budget agreement in 2017 that prohibited any changes to NIH overhead policy. This provision has been renewed every year since then.
In their decision, the appeals court found it unnecessary to consider the broader implications or questions of arbitrary capriciousness, as the Congressional rider specifically prohibits altering the NIH's indirect cost policies. The judges concluded that the Trump administration failed to present a valid justification for the policy change and ultimately upheld the lower-court ruling to block its implementation.
This decision provides relief to research universities, which heavily rely on these funding costs to support their operations. With Congress having already passed a law to protect these rates, it seems increasingly unlikely that any further attempts to drastically reduce them will be successful.
A US appeals court has agreed with a lower-court ruling that the Trump administration's attempt to drastically cut costs for university research funding was blocked by Congress. The NIH policy change, which would have imposed a uniform 15% flat rate on indirect costs, would have been catastrophic for many universities, with many potentially being forced into financial ruin.
Indirect costs cover expenses such as utilities, facilities for research animals, and building maintenance that are not directly associated with the research project itself. These costs can be quite high due to variations in location, where universities in urban areas must pay more for buildings and staff salaries than their rural counterparts.
The NIH had attempted to change these rates from a negotiated system where costs were estimated using formulas provided by the agency. The Trump administration sought to set an arbitrary flat rate of 15% across all grants.
However, Congress intervened long ago in this issue when they attached a rider to the budget agreement in 2017 that prohibited any changes to NIH overhead policy. This provision has been renewed every year since then.
In their decision, the appeals court found it unnecessary to consider the broader implications or questions of arbitrary capriciousness, as the Congressional rider specifically prohibits altering the NIH's indirect cost policies. The judges concluded that the Trump administration failed to present a valid justification for the policy change and ultimately upheld the lower-court ruling to block its implementation.
This decision provides relief to research universities, which heavily rely on these funding costs to support their operations. With Congress having already passed a law to protect these rates, it seems increasingly unlikely that any further attempts to drastically reduce them will be successful.